My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 119

    1.

    Treatment of diabetic ketoacidosis with subcutaneous insulin aspart.

    Umpierrez GE, Cuervo R, Karabell A, Latif K, Freire AX, Kitabchi AE.

    Diabetes Care. 2004 Aug;27(8):1873-8.PMID: 15277410 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.

    Umpierrez GE, Latif K, Stoever J, Cuervo R, Park L, Freire AX, E Kitabchi A.

    Am J Med. 2004 Sep 1;117(5):291-6.PMID: 15336577 [PubMed - indexed for MEDLINE]Related articles

    3.

    Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients.

    Ersöz HO, Ukinc K, Köse M, Erem C, Gunduz A, Hacihasanoglu AB, Karti SS.

    Int J Clin Pract. 2006 Apr;60(4):429-33.PMID: 16620355 [PubMed - indexed for MEDLINE]Related articles

    4.

    Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial.

    Umpierrez GE, Jones S, Smiley D, Mulligan P, Keyler T, Temponi A, Semakula C, Umpierrez D, Peng L, Cerón M, Robalino G.

    Diabetes Care. 2009 Jul;32(7):1164-9. Epub 2009 Apr 14.PMID: 19366972 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis.

    Della Manna T, Steinmetz L, Campos PR, Farhat SC, Schvartsman C, Kuperman H, Setian N, Damiani D.

    Diabetes Care. 2005 Aug;28(8):1856-61.PMID: 16043723 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study.

    Wiggam MI, O'Kane MJ, Harper R, Atkinson AB, Hadden DR, Trimble ER, Bell PM.

    Diabetes Care. 1997 Sep;20(9):1347-52.PMID: 9283776 [PubMed - indexed for MEDLINE]Related articles

    7.

    Insulin glargine supplementation during early management phase of diabetic ketoacidosis in children.

    Shankar V, Haque A, Churchwell KB, Russell W.

    Intensive Care Med. 2007 Jul;33(7):1173-8. Epub 2007 May 17.PMID: 17508198 [PubMed - indexed for MEDLINE]Related articles

    8.

    Is subcutaneous administration of rapid-acting insulin as effective as intravenous insulin for treating diabetic ketoacidosis?

    Mazer M, Chen E.

    Ann Emerg Med. 2009 Feb;53(2):259-63.PMID: 19177639 [PubMed - indexed for MEDLINE]Related articles

    9.

    Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children.

    Noyes KJ, Crofton P, Bath LE, Holmes A, Stark L, Oxley CD, Kelnar CJ.

    Pediatr Diabetes. 2007 Jun;8(3):150-6.PMID: 17550425 [PubMed - indexed for MEDLINE]Related articles

    10.

    Is a priming dose of insulin necessary in a low-dose insulin protocol for the treatment of diabetic ketoacidosis?

    Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J.

    Diabetes Care. 2008 Nov;31(11):2081-5. Epub 2008 Aug 11.PMID: 18694978 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Therapy of severe diabetic ketoacidosis. Zero-mortality under very-low-dose insulin application.

    Wagner A, Risse A, Brill HL, Wienhausen-Wilke V, Rottmann M, Sondern K, Angelkort B.

    Diabetes Care. 1999 May;22(5):674-7.PMID: 10332664 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.

    Bi YF, Zhao LB, Li XY, Wang WQ, Sun SY, Chen YH, Hong J, Su TW, Liu JM, Ning G.

    Chin Med J (Engl). 2007 Oct 5;120(19):1700-3.PMID: 17935674 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro.

    Reichel A, Rietzsch H, Köhler HJ, Pfützner A, Gudat U, Schulze J.

    Exp Clin Endocrinol Diabetes. 1998;106(3):168-72.PMID: 9710355 [PubMed - indexed for MEDLINE]Related articles

    14.

    Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises.

    Umpierrez GE, Clark WS, Steen MT.

    Diabetes Care. 1997 Apr;20(4):479-83.PMID: 9096964 [PubMed - indexed for MEDLINE]Related articles

    15.

    Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.

    Bode BW, Strange P.

    Diabetes Care. 2001 Jan;24(1):69-72.PMID: 11194244 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.

    Attia N, Jones TW, Holcombe J, Tamborlane WV.

    Diabetes Care. 1998 May;21(5):817-21.PMID: 9589247 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Prevalence and characteristics of type 2 diabetes mellitus in 9-18 year-old children with diabetic ketoacidosis.

    Sapru A, Gitelman SE, Bhatia S, Dubin RF, Newman TB, Flori H.

    J Pediatr Endocrinol Metab. 2005 Sep;18(9):865-72.PMID: 16279364 [PubMed - indexed for MEDLINE]Related articles

    18.

    A direct efficacy and safety comparison of insulin aspart, human soluble insulin, and human premix insulin (70/30) in patients with type 2 diabetes.

    Bretzel RG, Arnolds S, Medding J, Linn T.

    Diabetes Care. 2004 May;27(5):1023-7.PMID: 15111514 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Insulin therapy for diabetic ketoacidosis. Bolus insulin injection versus continuous insulin infusion.

    Butkiewicz EK, Leibson CL, O'Brien PC, Palumbo PJ, Rizza RA.

    Diabetes Care. 1995 Aug;18(8):1187-90.PMID: 7587857 [PubMed - indexed for MEDLINE]Related articles

    20.

    Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin.

    Rosenfalck AM, Thorsby P, Kjems L, Birkeland K, Dejgaard A, Hanssen KF, Madsbad S.

    Acta Diabetol. 2000 Mar;37(1):41-6.PMID: 10928235 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity